Nontherapeutic Risk Factors of Different Grouped Stage IIIC Breast Cancer Patients' Mortality: A Study of the US Surveillance, Epidemiology, and End Results …
Y Qiu, H Chen, Y Dai, B Bao, L Tian… - The Breast …, 2022 - Wiley Online Library
Objectives. Stage IIIC breast cancer, as a local advanced breast cancer, has a poor
prognosis compared with that of early breast cancer. We further investigated the risk factors …
prognosis compared with that of early breast cancer. We further investigated the risk factors …
Clinical outcomes of N3 breast cancer: a real-world study of a single institution and the us surveillance, epidemiology, and end results (SEER) database
X Ai, X Liao, J Li, P Tang, J Jiang - Cancer Management and …, 2020 - Taylor & Francis
Background Although stage IIIC (any TN3M0) breast cancer is known to have a dismal
prognosis, the clinical outcome of current standard management and the prognostic …
prognosis, the clinical outcome of current standard management and the prognostic …
[PDF][PDF] Molecular subtypes of breast cancer: clinicopathological characteristics and prognosis
JB de Lima, ICR da Silva, JR de Oliveira - 2024 - pdfs.semanticscholar.org
Breast cancer (BC) is considered one of the most important neoplasms regarding morbidity
and mortality worldwide. Molecular classification using immunohistochemistry has been …
and mortality worldwide. Molecular classification using immunohistochemistry has been …
Role of antibody-secreting cells and tertiary lymphoid structures in breast tumors immunosurveillance
Y Lounici - 2022 - theses.hal.science
B cells emerge as critical actors in the tumor microenvironment, but their diversity and
clinical impact is still poorly investigated and remain controversial. Multiparametric flow …
clinical impact is still poorly investigated and remain controversial. Multiparametric flow …
Postmastectomy Radiotherapy in T1–2 Women Breast Cancer Patients with 1–3 Positive Axillary Lymph Nodes: A Propensity Score Matched SEER Analysis
G Xu, S Bu, X Wang, H Ge - 2020 - researchsquare.com
Purpose: The application of postmastectomy radiotherapy (PMRT) in T1–2 women breast
cancer patients with 1–3 positive lymph nodes has been controversial. We sought to …
cancer patients with 1–3 positive lymph nodes has been controversial. We sought to …